VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.

Abad C, Jayaram B, Becquet L, Wang Y, O'Dorisio SM, Waschek JA, Tan Y-V

J Neuroinflammation. 2016; 13(1):169. Epub 2016 Jun 29. PMID: 27357191. Abstract